<p>Source: Arredondo et al. (2012) Costos y consecuencias financieras del cambio en el perfil epidemiológico en México. INSP–Update of probabilistic models, January 2012.</p><p>Exchange rate: January 2012, 1 US$ = 13.35 Mexican $.</p><p>95% CIs. Box–Pierce statistical test (p<0.05).</p><p>IMSS, Mexican Institute for Social Security; ISSSTE, Institute for Social Security and Services for State Workers; na, not available; PHI, private health insurance; SSA, Ministry of Health.</p
Diabetes is becoming one of the major public health problems because a great proportion of the healt...
Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) am...
Objetivo. Estimar el consumo de recursos sanitarios empleados en prevención y el tratamiento de paci...
OBJECTIVE — To identify the costs and economic consequences of expected changes in the demand for he...
AbstractThe main objective was to identify economic burden from epidemiological changes and expected...
Resumen: Objetivo: Estimar para el Instituto los costos directos de las hospitalizaciones por diabe...
cdc:85309National diabetes statistics report, 2020 : estimates of diabetes and its burden in the Uni...
<p>Costs from epidemiological changes expected to diabetes and hypertension in Mexico for the period...
The global age standardized prevalence of type 2 diabetes (T2DM) has doubled (4.7% to 8.5%) over the...
This manuscript presents the results of an analysis that highlights the challenges of diabetes as a ...
Objective To measure the economic burden associated with diabetes mellitus in Latin America and the ...
OBJETIVO: Estimar los costos directos de la atención médica a pacientes con diabetes mellitus tipo 2...
ABSTRACT OBJECTIVE To analyze the epidemiological and economic burden of the health services deman...
Background: Chronic diseases (CD) are a public health emergency in Mexico. Despite concern regarding...
The prevalence of diabetes among adults in Mexico has increased markedly from 6.7 % in 1994 to 14.7 ...
Diabetes is becoming one of the major public health problems because a great proportion of the healt...
Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) am...
Objetivo. Estimar el consumo de recursos sanitarios empleados en prevención y el tratamiento de paci...
OBJECTIVE — To identify the costs and economic consequences of expected changes in the demand for he...
AbstractThe main objective was to identify economic burden from epidemiological changes and expected...
Resumen: Objetivo: Estimar para el Instituto los costos directos de las hospitalizaciones por diabe...
cdc:85309National diabetes statistics report, 2020 : estimates of diabetes and its burden in the Uni...
<p>Costs from epidemiological changes expected to diabetes and hypertension in Mexico for the period...
The global age standardized prevalence of type 2 diabetes (T2DM) has doubled (4.7% to 8.5%) over the...
This manuscript presents the results of an analysis that highlights the challenges of diabetes as a ...
Objective To measure the economic burden associated with diabetes mellitus in Latin America and the ...
OBJETIVO: Estimar los costos directos de la atención médica a pacientes con diabetes mellitus tipo 2...
ABSTRACT OBJECTIVE To analyze the epidemiological and economic burden of the health services deman...
Background: Chronic diseases (CD) are a public health emergency in Mexico. Despite concern regarding...
The prevalence of diabetes among adults in Mexico has increased markedly from 6.7 % in 1994 to 14.7 ...
Diabetes is becoming one of the major public health problems because a great proportion of the healt...
Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) am...
Objetivo. Estimar el consumo de recursos sanitarios empleados en prevención y el tratamiento de paci...